MedPath

Evaluation of Peripartum Blood Loss and Postpartum Anaemia in Macrosomia & Gemini

Completed
Conditions
Bloodloss in Pregnancy
Interventions
Other: Observation of Blood loss
Registration Number
NCT06201910
Lead Sponsor
Goethe University
Brief Summary

Anaemia in pregnant women occurs at a haemoglobin (Hb) concentration \<11 g/dL and treatment is essential to prevent increased maternal morbidity, fetal morbidity and mortality. Studies show a distinct risk of haemorrhage in pregnant women due to increased uterine dilatation, due to twins or macrosomic singletons. Currently, prepartum anaemia management, the influence of anaemia and the administration of foreign blood concentrates are insufficiently studied. The investigators intend to conduct a monocentric retrospective analysis of this subcohort.

Detailed Description

Patient blood management is essentially based on three pillars, and a meta-analysis has already shown that consistent use can reduce transfusions and mortality. The WHO defines anaemia in pregnant patients as a haemoglobin (Hb) concentration \<11 g/dl.

Treatment of iron deficiency anaemia is essential because data show that iron deficiency anaemia is associated with increased maternal morbidity, fetal morbidity and mortality. Studies show a separate risk of bleeding in pregnant women due to increased uterine prolapse, for example in twin pregnancies or macrosomic singletons. At present, the prepartum anaemia management of patients, the influence of anaemia and the administration of foreign blood concentrates are insufficiently studied, which the investigators intend to investigate.

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
575
Inclusion Criteria
  • Pregnancy
Exclusion Criteria
  • pre-existing coagulation disorder

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
ControllObservation of Blood lossPregnant women without uterine dilation due to a twin pregnancy or a macrosomic singleton
MakrosomeObservation of Blood lossPregnant women with uterine dilation due to a macrosomic singleton
GeminiObservation of Blood lossPregnant women with uterine dilation due to a twin pregnancy
Primary Outcome Measures
NameTimeMethod
BloodlossWithin the first 24 hours after delivery

Blood loss measured by haemoglobin value

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (2)

University Hospital Frankfurt

🇩🇪

Frankfurt, Hessen, Germany

Goethe University

🇩🇪

Frankfurt, Hessen, Germany

© Copyright 2025. All Rights Reserved by MedPath